Skip to main content

Tempus AI, Inc.

For the period ended Sep 30, 2025. Filed Nov 4, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 4, 2025

TEM$80.54-4.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

Nine Months Ended September 30,
20252024
Operating activities
Net loss$(190,862)$(692,795)
Adjustments to reconcile net loss to net cash used in operating activities
Change in fair value of warrant liability$—$42,400
Stock-based compensation79,408509,351
Gain on warrant exercise—(173)
Gain on marketable equity securities(4,731)(5,119)
Loss on debt extinguishment12,034—
Deferred income taxes(46,216)—
Losses from equity method investments2,4651,692
Amortization of original issue discount2,6151,036
Amortization of deferred financing fees398383
Change in fair value of contingent consideration—165
Change in fair value of holdback liability291—
Amortization of warrant contract asset—3,633
Depreciation and amortization75,41627,788
Provision for bad debt expense767545
Provision for obsolete inventory1,135—
Change in fair value of warrant asset—(18,302)
Non-cash operating lease costs7,8664,670
Minimum accretion expense10985
PIK interest added to principal8,8396,567
Change in assets and liabilities
Accounts receivable(1)(63,199)(51,699)
Inventory(6,537)(7,293)
Prepaid expenses and other current assets(3,991)(14,040)
Investments and other assets(16,700)(410)
Accounts payable(18,528)(24,776)
Related party asset(25,000)—
Deferred revenue(2)17,398(1,052)
Deferred other income(11,966)43,876
Accrued data licensing fees3,730(4,250)
Accrued expenses & other(5,179)23,371
Interest payable10,28811,208
Operating lease liabilities(11,152)(6,655)
Net cash used in operating activities$(181,302)$(149,794)

(1) Includes increase in related party accounts receivable of $2,352 and $1,909 as of September 30, 2025 and September 30, 2024, respectively.

(2) Includes increase in related party deferred revenue of $19,918 and $0 as of September 30, 2025 and September 30, 2024, respectively.

Nine Months Ended September 30,
20252024
Investing activities
Purchases of property and equipment$(16,294)$(14,159)
Proceeds from sale of marketable equity securities8,31623,098
Purchases of marketable equity securities—(36,183)
Business combinations, net of cash acquired (Note 4)(375,025)—
Investment in joint venture—(95,186)
Purchases of capitalized software(4,635)—
Net cash used in investing activities$(387,638)$(122,430)
Financing activities
Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions$—$381,951
Tax withholding related to net share settlement of restricted stock units—(69,918)
Issuance of Series G-5 Preferred Stock—199,750
Payment of deferred offering costs(501)(8,587)
Dividends paid—(5,625)
Proceeds from revolving credit facility, net of original issue discount98,000—
Proceeds from long-term debt, net of original issue discount196,000—
Proceeds from convertible senior notes, net of initial purchasers' discount726,497—
Payment of deferred financing fees(1,255)—
Payment of indemnity holdback related to acquisition—(813)
G-4 Special Payment—(2,250)
Principal payments on long-term debt(276,892)—
Prepayment premium on long-term debt(7,841)—
Purchases of capped call(41,775)—
Proceeds from issuance of common stock in connection with at-the-market offering, net of commissions195,499—
Net cash provided by financing activities$887,732$494,508
Effect of foreign exchange rates on cash$(78)$(13)
Net increase in Cash, Cash Equivalents and Restricted Cash$318,714$222,271
Cash, cash equivalents and restricted cash, beginning of period341,835166,607
Cash, cash equivalents and restricted cash, end of period$660,549$388,878
Cash, Cash Equivalents and Restricted Cash are Comprised of:
Cash and cash equivalents$655,918$388,006
Restricted cash and cash equivalents4,631872
Total cash, cash equivalents and restricted cash$660,549$388,878
Supplemental disclosure of cash flow information
Cash paid during the year for interest$37,349$20,899
Cash paid for income taxes$573$127
Nine Months Ended September 30,
20252024
Supplemental disclosure of noncash investing and financing activities
Dividends payable$—$5,487
Purchases of property and equipment, accrued but not paid$3,724$6,706
Redemption of convertible promissory note$22,721$18,664
Non-voting common stock issued in connection with business combinations$—$344
Deferred offering costs, accrued but not yet paid$320$179
Deferred financing fees, accrued but not yet paid$489$—
Reclassification of deferred offering costs to additional paid-in capital upon at-the-market offering$821$—
Operating lease liabilities arising from obtaining right-of-use assets$22,670$550
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering$—$1,348,809
Taxes related to net share settlement of restricted stock units not yet paid$—$164
Reclassification of deferred offering costs to additional paid-in capital upon initial public offering$—$12,347
Class A Common Stock issued in connection with business combinations$403,154$—
Class A Common Stock issued in connection with license agreement$1,443$—
Issuance of Series G-3 Preferred Stock$—$3,809
Issuance of Series G-4 Preferred Stock$—$611
Convertible promissory note principal reset due to amendment$72,488$—

CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.